Merck 2026 Outlook Misses as Gardasil Sales Drop 35% [Yahoo! Finance]
Merck & Company, Inc. (new) (MRK)
Last merck & company, inc. (new) earnings: 4/28 06:45 am
Check Earnings Report
US:NYSE Investor Relations:
investors.merck.com/home/default.aspx
Company Research
Source: Yahoo! Finance
that came in below market expectations, with continued uncertainty around its Gardasil HPV vaccine overshadowing momentum from newer medicines. The company projected full-year sales of $65.5 billion to $67 billion and adjusted earnings of up to $5.15 a share, figures that did not assume any Gardasil shipments to China next year after shipments were previously paused through the end of 2025. That absence reflects weaker demand in the market, rising competition from lower-priced local vaccines, and broader economic and policy pressures, factors that weighed on sentiment as the stock fell as much as 3.2% in pre-market trading despite being up 7.7% year to date through Monday's close. Warning! GuruFocus has detected 9 Warning Sign with MRK. Is MRK fairly valued? Test your thesis with our free DCF calculator. The pressure on Gardasil has been evident in recent results, with fourth-quarter sales of $1.03 billion, down 35% from a year earlier, though still ahead of more pessimistic exp
Show less
Read more
Impact Snapshot
Event Time:
MRK
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
MRK alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
MRK alerts
High impacting Merck & Company, Inc. (new) news events
Weekly update
A roundup of the hottest topics
MRK
News
- Are Wall Street Analysts Bullish on Moderna Stock? [Yahoo! Finance]Yahoo! Finance
- Merck & Co., Inc. (MRK) Q4 2025 Earnings Call Transcript [Seeking Alpha]Seeking Alpha
- Merck (MRK) Reports Q4 Earnings: What Key Metrics Have to Say [Yahoo! Finance]Yahoo! Finance
- Merck (MRK) Is Up 5.6% After Cautious 2026 Outlook And Ongoing Oncology Investment Plans – What's Changed [Yahoo! Finance]Yahoo! Finance
- Here's Why Gilead Sciences Stock Surged 21% in a Month [Yahoo! Finance]Yahoo! Finance
MRK
Earnings
- 2/3/26 - Beat
MRK
Sec Filings
- 2/3/26 - Form 8-K
- 1/28/26 - Form 4
- 1/28/26 - Form 4
- MRK's page on the SEC website